Syros Pharmaceuticals

(OTC) SYRS

Current Price$0.00

Market Cap$5.40K

Since IPO (2016)-100%

5 Year-100%

1 Year-99%

1 Month-56%

Syros Pharmaceuticals Financials at a Glance

Market Cap

$5.40K

Revenue (TTM)

$386.00K

Net Income (TTM)

-$97.82M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

5.79 (High)

Dividend

$0.00

Beta (Volatility)

5.79 (High)

Price

$0.00

Volume

65,712

Open

$0.00

Price

$0.00

Volume

65,712

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.04

Dividend

$0.00

Beta (Volatility)

5.79 (High)

Price

$0.00

Volume

65,712

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.04

SYRS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Syros Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Conley Chee, MBA; Nancy A. Simonian, MD

Website

www.syros.com

Headquarters

Cambridge, MA 02140, US

SYRS Financials

Key Financial Metrics (TTM)

Gross Margin

77%

Operating Margin

-13%

Net Income Margin

-17%

Return on Equity

Return on Capital

-98%

Return on Assets

-98%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.40K

Shares Outstanding

26.83M

Volume

65.71K

Avg. Volume

11.76K

Financials (TTM)

Gross Profit

$7.68M

Operating Income

-$128.99M

EBITDA

-$157.20M

Operating Cash Flow

-$109.71M

Capital Expenditure

-$272.00K

Free Cash Flow

-$109.98M

Cash & ST Invst.

$139.53M

Total Debt

$62.08M

Syros Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2024YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$325.00K

-110.3%

Gross Margin

0.00%

N/A

Market Cap

$5.40K

N/A

Market Cap/Employee

$79.41

N/A

Employees

N/A

Net Income

-$6.40M

+84.1%

EBITDA

-$4.76M

+87.5%

Quarterly Fundamentals

Name

Q3 2024YOY CHG

Net Cash

-$1.95M

-104.1%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$57.64M

-1.6%

Short Term Debt

$2.58M

-58.0%

Return on Assets

-97.86%

N/A

Return on Invested Capital

-98.09%

N/A

Free Cash Flow

-$20.69M

+35.1%

Operating Cash Flow

-$20.69M

+35.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VRPXVirpax Pharmaceuticals, Inc.

VRPXVirpax Pharmaceuticals, Inc.$0.00+0.00%

SLXNWSilexion Therapeutics Ltd.

SLXNWSilexion Therapeutics Ltd.$0.02+33.73%

VINCVincerx Pharma, Inc.

VINCVincerx Pharma, Inc.$0.01+1.18%

PPBTPurple Biotech Ltd.

PPBTPurple Biotech Ltd.$2.99+0.00%

DRMADermata Therapeutics, Inc.

DRMADermata Therapeutics, Inc.$1.34+3.08%

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.09-0.46%

KTTAPasithea Therapeutics Corp.

KTTAPasithea Therapeutics Corp.$0.72-0.04%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$224.35+0.06%

NOKNokia

NOKNokia$16.24+0.09%

HPEHewlett Packard Enterprise

HPEHewlett Packard Enterprise$47.39+0.10%

INTCIntel

INTCIntel$109.33-0.05%

ONDSOndas

ONDSOndas$13.46+0.02%

MSFTMicrosoft

MSFTMicrosoft$460.94+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47-0.09%

Questions About SYRS

What is the current price of Syros Pharmaceuticals?

Syros Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Syros Pharmaceuticals?

Over the past 52 weeks, Syros Pharmaceuticals has traded between $0.00 and $0.04.

How much debt does Syros Pharmaceuticals have?

As of the most recent reporting period, Syros Pharmaceuticals reported total debt of $60.23M.

How much cash does Syros Pharmaceuticals have on hand?

Syros Pharmaceuticals reported $58.28M in cash and cash equivalents in its most recent financial results.

What is Syros Pharmaceuticals’s dividend yield?

Syros Pharmaceuticals does not currently have a dividend yield.

Syros Pharmaceuticals

Syros Pharmaceuticals Financials at a Glance

SYRS News

Why Syros Pharmaceuticals Stock Is Soaring Today

Why IBM, Extraction Oil & Gas, and Syros Pharmaceuticals Slumped Today

Here's Why Syros Pharmaceuticals Is Collapsing Today

Here's Why Syros Pharmaceuticals Got Crushed Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Syros Pharmaceuticals

SYRS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Syros Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SYRS

What is the current price of Syros Pharmaceuticals?

What is the 52-week range for Syros Pharmaceuticals?

How much debt does Syros Pharmaceuticals have?

How much cash does Syros Pharmaceuticals have on hand?

What is Syros Pharmaceuticals’s dividend yield?

Premium Investing Services